Selina J Chavda

9PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 23, 2021
Applying current smouldering myeloma risk models to a UK single-centre cohort and clinical features at progression.

Louise Ainley, Marquita Camilleri, Selina J Chavda

|Oct 11, 2021
Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors.

Wei Yee Chan, Lara Howells, William Wilson

|Jul 29, 2021
Development of antibody response to SARS-CoV-2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy.

Wei Yee Chan, Emilie Sanchez, Selina J Chavda

|Mar 02, 2021
Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study.

Marquita Camilleri, Maria Cuadrado, Elizabeth Phillips

|Nov 25, 2020
DT-PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation.

Louise Ainley, Selina J Chavda, Nicholas Counsell

|Oct 26, 2020
Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'.

Thomas A Fox, Ethan Troy-Barnes, Amy A Kirkwood

Pageof 2

Frequent Collaborators

8 joint publications

Kwee Yong

4 joint publications

Louise Ainley

3 joint publications

Rakesh Popat

3 joint publications

Marie Scully